对抗……的抗生素替代品
Alternatives to Antibiotics against .
作者信息
Broncano-Lavado Antonio, Senhaji-Kacha Abrar, Santamaría-Corral Guillermo, Esteban Jaime, García-Quintanilla Meritxell
机构信息
Department of Clinical Microbiology, IIS-Fundación Jiménez Díaz, Av. Reyes Católicos, 2, 28040 Madrid, Spain.
CIBERINFEC-Infectious Diseases CIBER, Madrid, Spain.
出版信息
Antibiotics (Basel). 2022 Sep 28;11(10):1322. doi: 10.3390/antibiotics11101322.
Abstract
complex is extremely difficult to treat. Intrinsic and acquired bacterial resistance makes this species one of the most challenging pathogens and treatments last from months to years, associated with potential risky antibiotic toxicity and a high number of failures. Nonantibiotic antimicrobial agents against this microorganism have recently been studied so as to offer an alternative to current drugs. This review summarizes recent research on different strategies such as host modulation using stem cells, photodynamic therapy, antibiofilm therapy, phage therapy, nanoparticles, vaccines and antimicrobial peptides against both in vitro and in vivo.
摘要
该复合体极难治疗。内在和获得性细菌耐药性使该物种成为最具挑战性的病原体之一，治疗持续数月至数年，伴有潜在的危险抗生素毒性和大量治疗失败情况。最近对针对这种微生物的非抗生素抗菌剂进行了研究，以便为现有药物提供替代方案。本综述总结了最近关于不同策略的研究，如使用干细胞进行宿主调节、光动力疗法、抗生物膜疗法、噬菌体疗法、纳米颗粒、疫苗和抗菌肽，包括体外和体内研究。
相似文献
1
Alternatives to Antibiotics against .对抗……的抗生素替代品
Antibiotics (Basel). 2022 Sep 28;11(10):1322. doi: 10.3390/antibiotics11101322.
2
Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus.与囊性纤维化（CF）多药治疗相关的非抗生素对脓肿分枝杆菌的抗分枝杆菌活性。
Int J Mycobacteriol. 2018 Oct-Dec;7(4):358-360. doi: 10.4103/ijmy.ijmy_142_18.
3
Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus.哌啶-4-羧酰胺类化合物靶向分枝杆菌 DNA 回旋酶。
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0067621. doi: 10.1128/AAC.00676-21.
4
Alternative and Experimental Therapies of Infections.感染的替代和实验疗法。
Int J Mol Sci. 2020 Sep 16;21(18):6793. doi: 10.3390/ijms21186793.
5
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.伊朗非结核分枝杆菌的体外抗菌药敏性
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.
6
Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.贝达喹啉和德拉马尼对非结核分枝杆菌（包括大环内酯类耐药临床分离株）的活性。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00665-19. Print 2019 Aug.
7
In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.游离态与纳米态三（对羧基苯基）卟啉合镓（III）体外抗鸟分枝杆菌和脓肿分枝杆菌效果及其在小鼠体内的生物分布
Mol Pharm. 2018 Mar 5;15(3):1215-1225. doi: 10.1021/acs.molpharmaceut.7b01036. Epub 2018 Feb 16.
8
Antimicrobial properties of basidiomycota macrofungi to isolated from patients with cystic fibrosis.从囊性纤维化患者中分离出的担子菌大型真菌的抗菌特性。
Int J Mycobacteriol. 2019 Jan-Mar;8(1):93-97. doi: 10.4103/ijmy.ijmy_167_18.
9
Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria.奥马环素对非结核分枝杆菌的药敏试验。
Antimicrob Agents Chemother. 2021 Feb 17;65(3). doi: 10.1128/AAC.01947-20.
10
Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus.对鸟分枝杆菌和脓肿分枝杆菌中 DNA 拓扑异构酶抑制剂 SPR719 的耐药性。
Microbiol Spectr. 2022 Feb 23;10(1):e0132121. doi: 10.1128/spectrum.01321-21. Epub 2022 Jan 12.
引用本文的文献
1
P3MA: A Promising Mycobacteriophage Infecting .P3MA：一种有前景的感染……的分枝杆菌噬菌体
Antibiotics (Basel). 2025 Aug 6;14(8):801. doi: 10.3390/antibiotics14080801.
2
Potency of all-D amino acid antimicrobial peptides derived from the bovine rumen microbiome on tuberculous and non-tuberculous mycobacteria.源自牛瘤胃微生物群的全D-氨基酸抗菌肽对结核分枝杆菌和非结核分枝杆菌的抗菌活性。
Curr Res Microb Sci. 2025 Apr 22;8:100395. doi: 10.1016/j.crmicr.2025.100395. eCollection 2025.
3
Clinical Trials involving : An update.涉及临床试验：最新情况。
Ulster Med J. 2025 Apr;94(1):28-30. Epub 2025 Apr 30.
4
Novel Synthetic Peptide Agelaia-12 Has Improved Activity Against Complex.新型合成肽Agelaia-12对复合物具有更高的活性。
Pathogens. 2024 Nov 13;13(11):994. doi: 10.3390/pathogens13110994.
5
Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities.具有抗菌活性的新型氨基和乙酰氨基奥酮的设计与合成
Antibiotics (Basel). 2024 Mar 26;13(4):300. doi: 10.3390/antibiotics13040300.
6
Biofilm prevention concentration of clarithromycin against clinically relevant species of nontuberculous mycobacteria.克拉霉素对临床相关非结核分枝杆菌种的生物膜预防浓度。
Rev Esp Quimioter. 2024 Jun;37(3):266-269. doi: 10.37201/req/014.2024. Epub 2024 Apr 11.
7
Effect of multidrug therapy on the prognosis of Mycobacterium avium complex pulmonary disease.多药治疗对鸟分枝杆菌复合群肺病预后的影响。
Sci Rep. 2024 Feb 23;14(1):4438. doi: 10.1038/s41598-024-55135-0.
8
Promising antibacterial efficacy of arenicin peptides against the emerging opportunistic pathogen Mycobacterium abscessus.阿雷新肽对新兴机会性病原体脓肿分枝杆菌具有良好的抗菌疗效。
J Biomed Sci. 2024 Jan 29;31(1):18. doi: 10.1186/s12929-024-01007-8.
9
Molecular Identification of Strains within the Complex and Determination of Resistance to Macrolides and Aminoglycosides.复杂型内菌株的分子鉴定及对大环内酯类和氨基糖苷类药物耐药性的测定。
Pol J Microbiol. 2023 Dec 16;72(4):491-506. doi: 10.33073/pjm-2023-048. eCollection 2023 Dec 1.
10
Mycothione reductase as a potential target in the fight against infections.巯基乙磺酸还原酶作为抗感染治疗的潜在靶点。
mSphere. 2024 Jan 30;9(1):e0066923. doi: 10.1128/msphere.00669-23. Epub 2023 Dec 12.
本文引用的文献
1
High-Throughput Screening Identifies Synthetic Peptides with Antibacterial Activity against and Serum Stability.高通量筛选鉴定出对[具体对象]具有抗菌活性且具有血清稳定性的合成肽。
ACS Omega. 2022 Jun 27;7(27):23967-23977. doi: 10.1021/acsomega.2c02844. eCollection 2022 Jul 12.
2
Nebulized Bacteriophage in a Patient With Refractory Lung Disease.雾化噬菌体治疗难治性肺部疾病患者
Open Forum Infect Dis. 2022 Apr 12;9(7):ofac194. doi: 10.1093/ofid/ofac194. eCollection 2022 Jul.
3
Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.噬菌体治疗分枝杆菌感染：20 例耐药分枝杆菌病患者中噬菌体的同情使用。
Clin Infect Dis. 2023 Jan 6;76(1):103-112. doi: 10.1093/cid/ciac453.
4
Viruses to the rescue-Use of bacteriophage to treat resistant pulmonary infections.病毒的拯救作用-噬菌体在耐药性肺部感染治疗中的应用。
Cell. 2022 May 26;185(11):1807-1808. doi: 10.1016/j.cell.2022.04.037.
5
Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection.针对脓肿分枝杆菌肺部感染的噬菌体工程改造的宿主和病原体反应。
Cell. 2022 May 26;185(11):1860-1874.e12. doi: 10.1016/j.cell.2022.04.024. Epub 2022 May 13.
6
2-Aminoimidazoles Inhibit Biofilms in a Zinc-Dependent Manner.2-氨基咪唑以锌依赖的方式抑制生物膜。
Int J Mol Sci. 2022 Mar 9;23(6):2950. doi: 10.3390/ijms23062950.
7
ALA_PDT Promotes Ferroptosis-Like Death of and Antibiotic Sterilization via Oxidative Stress.氨基乙酰丙酸光动力疗法通过氧化应激促进类似铁死亡的死亡及抗生素杀菌作用。
Antioxidants (Basel). 2022 Mar 14;11(3):546. doi: 10.3390/antiox11030546.
8
In vitro study of the effect of ALA-PDT on Mycobacterium abscessus and its antibiotic susceptibility.体外研究 ALA-PDT 对脓肿分枝杆菌及其抗生素敏感性的影响。
Photodiagnosis Photodyn Ther. 2022 Jun;38:102802. doi: 10.1016/j.pdpdt.2022.102802. Epub 2022 Mar 14.
9
Antibacterial peptide RP557 increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formation.抗菌肽 RP557 通过抑制生物膜形成来增加脓肿分枝杆菌对抗生素的敏感性。
Sci Total Environ. 2022 Feb 10;807(Pt 3):151855. doi: 10.1016/j.scitotenv.2021.151855. Epub 2021 Nov 20.
10
Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus.评估新型改良型抗菌肽对克拉霉素耐药的脓肿分枝杆菌的体外活性。
PLoS One. 2021 Nov 15;16(11):e0260003. doi: 10.1371/journal.pone.0260003. eCollection 2021.
Zotero 插件